Neurizon Therapeutics LimitedASX: NUZ

Dr Chris Bremer commences as Neurizon CEO

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX ·

Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com Suite 2, Level 11, 385 Bourke Street, Melbourne, VIC 3000 Tel: +61 3 9692 7222 Dr Chris Bremer commences as Neurizon Chief Executive Officer Highlights: ? Dr Chris Bremer has commenced as Chief Executive Officer, marking an...

View Attachment

6ix hasn’t read this filing yet.

Neurizon Therapeutics Limited on 6ix

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases